SCHEMBL24314980

SCHEMBL24314980

COc1cccc(-c2ccc(F)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 2/20 0.58
ABL1 P00519 2/20 0.58
ABCB1 P08183 2/20 0.58
BCR P11274 2/20 0.58
MAOB P27338 3/20 0.57
NFE2L2 Q16236 1/20 0.56
CYP1A2 P05177 2/20 0.55
CYP3A4 P08684 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C19 P33261 2/20 0.55
CYP1A1 P04798 1/20 0.55
CYP2E1 P05181 1/20 0.55
CYP2C8 P10632 1/20 0.55
CYP2A6 P11509 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP4B1 P13584 1/20 0.55
CYP2B6 P20813 1/20 0.55
CYP3A5 P20815 1/20 0.55
CYP2A7 P20853 1/20 0.55
CYP3A7 P24462 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30610970 1.00 ALDH1A3 (0.58) ALDH1A3ABL1ABCB1BCRMAOB
SCHEMBL1180343 0.89 ABL1 (0.69) ABL1ABCB1BCRMAOBCYP1A2
SCHEMBL15624598 0.86 NFE2L2 (0.59) ABL1ABCB1BCRMAOBNFE2L2
SCHEMBL792197 0.85 ABL1 (0.77) ABL1ABCB1BCRMAOBCYP1A2
SCHEMBL13247865 0.85 ABL1 (0.64) ABL1ABCB1BCRMAOBCYP1A2
SCHEMBL1180412 0.85 ABL1 (0.77) ABL1ABCB1BCRMAOBCYP1A2
SCHEMBL29489425 0.85 CYP3A4 (0.73) ABL1ABCB1BCRMAOBCYP1A2
SCHEMBL196765 0.85 CYP3A4 (0.73) ABL1ABCB1BCRMAOBCYP1A2
SCHEMBL26226381 0.84 CYP1A1 (0.61) ABL1ABCB1BCRMAOBNFE2L2
SCHEMBL1181204 0.83 ABL1 (0.81) ABL1ABCB1BCRMAOBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076820-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-04-14 WO disclosed